October 11, 2023
A split Ninth Circuit declined Wednesday to revive an iRhythm Technologies investor's securities suit alleging the company made misrepresentations about Medicare's process for setting reimbursement rates for iRhythm's heart monitor patch, with the majority finding the investor lacks standing to appeal since he isn't a party to the case.